| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Biochemistry Research Laboratory, School of Postgraduate Medicine, Keele University [S. R., A. A. F., R. C. S.], and Department of Dermatology [J. T. L., H. R., A. G. S.], North Staffordshire Hospital, Stoke-on-Trent ST4 7PA, Staffordshire; Department of Dermatology, Royal Cornwall Hospitals, Truro TR1 2HZ, Cornwall [B. B.]; Department of Dermatology, Leicester Royal Infirmary, Leicester LE1 5WW [P. E. H.]; and Department of Mathematics, Keele University, Staffordshire ST5 5BG [P. W. J.], England
We previously reported associations between numbers of basal cell carcinomas (BCCs) and glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P450 (CYP2D6) genotypes. Thus, although GSTM1 AB is protective, GSTM1 null, GSTT1 null, and CYP2D6 EM are associated with increased numbers of lesions. Here, we examine the hypothesis that these genotypes are associated with high-risk subgroups. The subgroup studied comprised 119 patients with more than one previously unidentified BCC at first or later presentations [multiple presentation phenotype (MPP)]. These patients were part of a group of 773 BCC patients that also included 567 patients with one BCC and 87 patients with only one lesion at each presentation [single presentation phenotype (SPP)] but who developed multiple BCCs. The number of tumors in the MPP was significantly greater than that in the SPP groups. In the MPP but not SPP patients, GSTM1 AB, GSTT1 null, and CYP2D6 EM were significantly associated with BCC numbers, suggesting that previously observed associations reflect the influence of these genes only in the MPP cases. There was no evidence that MPP patients had received more UV exposure. We also determined whether the increased numbers of BCC in the MPP cases reflects an association with the truncal tumor phenotype. The values of the rate ratios indicated that the MPP is a marker for the risk of many BCCs, although the combination of MPP and a truncal tumor is a higher-risk phenotype. The data demonstrate the heterogeneity in BCC patients, which reflects differences in genetic factors that determine skin response to UV.
This article has been cited by other articles:
![]() |
J. Ramos, J. Villa, A. Ruiz, R. Armstrong, and J. Matta UV Dose Determines Key Characteristics of Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ramachandran, A. A. Fryer, T. Lovatt, A. Smith, J. Lear, P. W. Jones, and R. C. Strange The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation Carcinogenesis, December 1, 2002; 23(12): 2051 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al. Metabolic Gene Polymorphism Frequencies in Control Populations Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Matthias, V. Jahnke, P. W. Jones, P. R. Hoban, J. E. Alldersea, S. F. Worrall, A. A. Fryer, and R. C. Strange Cyclin D1, Glutathione S-Transferase, and Cytochrome P450 Genotypes and Outcome in Patients with Upper Aerodigestive Tract Cancers: Assessment of the Importance of Individual Genes Using Multivariate Analysis Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 815 - 823. [Abstract] [Full Text] |
||||
![]() |
A. Clairmont, H. Sies, S. Ramachandran, J. T. Lear, A. G. Smith, B. Bowers, P. W. Jones, A. A. Fryer, and R. C. Strange Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci Carcinogenesis, July 1, 1999; 20(7): 1235 - 1240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |